Media Mentions
SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain Cancer
Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly pediatric brain cancer with a 2% five-year survival rate. To provide therapeutic options for patients and families, SonALAsense is partnering with clinicians at the Ivy Brain Tumor Center at Barrow Neurological Institute, Phoenix Children's Hospital, and other sites to conduct a phase 1/2 clinical trial for sonodynamic therapy (SDT). This is the first SDT trial for children.
Team at Ivy Brain Tumor Center works to cure ‘deadliest cancer in humans’
Dr. Nader Sanai spoke with local news station, ABC15 about new developments in brain cancer research and treatment on the fourth anniversary of Senator John McCain's death.
Ivy Brain Tumor Center discusses forms of treatment for rare aggressive brain cancer
Dr. Kelly Braun from the Ivy Brain Tumor Center at Barrow Neurological Institute spoke with Good Morning Arizona reporter Tess Rafols, about new developments and treatments for brain cancer.
Our Bioscience Economy
The Ivy Brain Tumor Center was recognized in a cover story by Greater Phoenix InBusiness as a top-ranked healthcare organization that provides top-notch care, innovation, and research excellence. Learn more -->
Ivy Brain Tumor Center Evaluates AZD1390 in Patients Diagnosed with Recurrent Grade IV Gliomas
A research team at the Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer, will evaluate AZD1390 in a Phase 0/1b clinical trial with patients diagnosed with recurrent grade IV gliomas. Onco'Zine covers the full trial and provides more details in this article.
Arizona on the Cutting Edge of Innovative Research Programs
Read about Ivy Brain Tumor Center's innovative research programs and how they are advancing brain cancer treatments. Learn how they are leading the way in Arizona and beyond.
Dr. Stuart Marcus Creates SonALAsense To Treat Deadly Cancers
The Ivy Brain Tumor Center collaborates with SonALAsense to conduct clinical trials that will rapidly assess a minimally invasive drug-device combination therapy in patients with glioblastoma. Dr. Stuart Marcus founder of SonALAsense discusses his journey with cancer research and how it led him to the discovery of this therapy.
Valley nurse fighting brain cancer sees promising results from treatment
Tim Jackson, a valley nurse, was diagnosed with brain cancer in February 2021. Tim and his wife, Amber, joined ABC15 to discuss their journey with glioblastoma and their exploration of clinical trials at the Ivy Brain Tumor Center. Read his full story here.
The Game On Glio Podcast: Episode 10 with Guest Dr. Sanai
Dr. Nader Sanai, director of Ivy Brain Tumor Center, joined Shannon Traphagen, Host of the “Game on Glio” podcast, to share his career in neurosurgical oncology. Dr. Sanai discusses the work happening at the Ivy Brain Tumor Center and the progress being made toward discovering a cure for brain cancer.
Ivy Brain Tumor Center’s core labs earn accreditation
The Ivy Brain Tumor Center is pleased to announce that its Pharmacodynamics (PD) Core and Pharmacokinetics (PK) Core laboratories passed their inspection and maintained accreditation by the Accreditation Committee of the College of American Pathologists (CAP). Learn more ->